Xizang Weixinkang Pharmaceutical Co., Ltd. Class A 603676

As global markets navigate a complex landscape characterized by fluctuating economic indicators and shifting investor sentiment, small-cap stocks in Asia present intriguing opportunities amid broader market dynamics. With the Russell 2000 Index outperforming the S&P 500 due to expectations of lower interest rates, investors may find value in exploring smaller companies that are well-positioned to benefit from regional economic trends and sector-specific growth drivers.